Form 4: Arteris VP Paul Alpern Executes Stock Option Plan
Statement of Changes in Beneficial Ownership
Arteris, Inc. VP and General Counsel Paul Alpern exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.
Summary
- Paul Alpern, VP and General Counsel of Arteris, Inc., exercised options to acquire 6,500 shares of common stock.
- The acquisition included 4,000 shares at $0.56 and 2,500 shares at $9.28.
- Following the exercise, Alpern sold a total of 12,502 shares at weighted average prices between $35.98 and $36.39.
- The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transactions were pre-planned and represent standard executive equity management.
Positives
- The executive maintains a significant remaining beneficial ownership of 80,384 shares of common stock.
- Transactions were conducted through a pre-established 10b5-1 plan, indicating a systematic approach to equity management rather than reactive selling.
Negatives
- The transaction represents a net reduction in the executive's direct shareholding in the company.
Risks
- Future share price volatility could impact the value of remaining unvested derivative securities held by the executive.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that routine insider selling via 10b5-1 plans is standard practice for corporate executives to manage personal liquidity and tax obligations, and generally does not signal a lack of confidence in the company's long-term prospects.
Comparison to Industry Standards
- The use of 10b5-1 plans is a best-practice standard for corporate officers to avoid potential conflicts of interest or allegations of insider trading.
- The volume of shares sold relative to the total holdings is consistent with typical executive compensation and diversification strategies observed in the semiconductor and software IP industry.
Stakeholder Impact
- Minimal impact on shareholders as the transactions were executed under a pre-arranged plan.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 2026-02-23 | Adoption date of the 10b5-1 trading plan. |
| 2026-06-01 | Date of the reported stock option exercises and share sales. |
| 2026-06-03 | Date of filing for the Form 4 statement. |
Keywords
Arteris, AIP, Insider Trading, Form 4, Stock Options, 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.